Top alopecia Articles in Dermatology

Coudability hairs: a revisited sign of alopecia areata assessed by trichoscopy
Clinical and Experimental Dermatology, 11/16/2009

Inui S et al. – Coudability hairs, more closely perceived by trichoscopy, are useful–markers for disease activity in AA and provide a surrogate–marker for the hair–pull test. [more...]

Serum T helper 1 cytokine levels are greater in patients with alopecia areata regardless of severity or atopy
Clinical and Experimental Dermatology, 11/16/2009

Barahmani N et al. – Increased Th1 serum cytokines (IL–2, IL–12 and interferon–gamma) and IL–1ra levels are associated with AA regardless of disease severity ... derm/acne,dermatology [more...]

Attitudes of dermatologists in the southeastern United States regarding treatment of alopecia areata
BMC Dermatology, 11/13/2009

Mukherjee N et al. – Survey results suggested that dermatologists recommend treatment less frequently for children than adults and for more advanced hair loss. NAAR data confirmed that ... dermatology [more...]

Does collapse of immune privilege in the hair-follicle bulge play a role in the pathogenesis of primary cicatricial alopecia
Clinical and Experimental Dermatology, 11/17/2009

Harries M et al. – The small series represents first preliminary attempts to ascertain whether bulge IP collapse may play a role in PCA pathogenesis. The authors ... variants, and show the presence of features consistent with bulge IP collapse in each case. [more...]

Alefacept for Severe Alopecia Areata
Archives of Dermatology, 11/17/2009

Strober BE et al. – Participants receiving alefacept for 12 consecutive weeks demonstrated no statistically significant improvement in AA when compared with a well–matched placebo–receiving group. Alefacept is ineffective for the treatment of ... pharmacology,cosmetic derm/acne,dermatology [more...]

Practical Guidelines for Evaluation of Loose Anagen Hair Syndrome
Archives of Dermatology, 10/20/2009

Cantatore–Francis JL et al. – Loose anagen hair syndrome is a common nonscarring alopecia in young girls with a history of sparse or fine hair. Before ordering extensive blood testing in young girls with diffusely thin hair, it is important [more...]

Drug Targeting Through Pilosebaceous Route
Current Drug Targets, 10/23/2009

glands or to the pilosebaceous unit is essential for the effectiveness of the drug. Increased accumulation in the pilosebaceous unit could treat alopecia, acne and skin cancer more efficiently and improve the effect of cosmetic substances and nutrients. [more...]

Weekly paclitaxel and cisplatin in the treatment of elderly advanced non-small cell lung cancer
Chinese Journal of Lung Cancer, 10/27/2009

months 1 year survival rate 58.3% Most common adverse events were leucopenia (60%), anemia (62%), nausea and vomiting (30%), alopecia (100%) No chemotherapy-related deaths [more...]

A randomized, phase III multicenter trial of gemcitabine in combination with carboplatin or paclitaxel versus paclitaxel plus carboplatin in patients with advanced or metastatic NSCLC
Annals of Oncology, 10/19/2009

rates (RRs) as follows: GC, 25.3%; GP, 32.1%; and PC, 29.8% The GC arm associated with greaterincidence of grade 3 or 4 hematologic events but lower rate of neurotoxicity and alopecia when compared with GP and PC [more...]

The role of bendamustine in the treatment of indolent non-Hodgkin lymphoma
Cancer Management and Research, 11/16/2009

patients. The cytotoxic activity of bendamustine has been shown to be synergistic with rituximab in hematological malignancies. The incidence of alopecia is significantly less than with other alkylating agents. Myelosuppression is the major toxicity associated with bendamustine. [more...]